SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is a major talking point as investors eagerly await its business update call, expecting Dr. PSS to reveal breakthroughs in Anktiva's global strategy and the BioShield platform, while simultaneously navigating intense community chatter around perceived short interest manipulation.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd (INDO) is trending amidst intense community debate following a steep sell-off, with many questioning potential dilution and market manipulation as the stock paradoxically plummets despite surging crude oil prices and escalating Middle East tensions driving other small-cap energy plays higher.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

Crowdstrike is trending after delivering a double beat on earnings with solid guidance, reinforcing its position as a cybersecurity leader amidst increasing global cyber threats. The community is actively discussing whether AI is a tailwind or a threat to the sector, with many viewing recent dips as a buying opportunity given the crucial and growing demand for advanced security solutions.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin (WEEDCOIN CRYPTO) is seeing strong community interest and positive momentum, largely driven by enthusiasm for the approaching 4/20 cannabis culture event. Investors are discussing its potential as a "culture coin" on the Solana blockchain, citing its consistent development and unique position within the expanding cannabis ecosystem.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is surging amid a flurry of positive developments, including a significant settlement in its patent dispute with Arbutus Biopharma and Genevant, the FDA's reversal to review its seasonal flu vaccine, and a European recommendation for its COVID-19/flu combination shot, driving strong community optimism for its pipeline and a potential short squeeze.

GitLab, Inc. engages in the intelligent DevSecOps platform for software innovation. The firm enables organizations to increase developer productivity, improve operational efficiency, reduce security and compliance risk, and accelerate digital transformation. The company was founded by Dmitriy Zaporozhets and Sid Sijbrandij in 2011 and is headquartered in San Francisco, CA.

Gitlab Inc - Ordinary Shares - Class A

Gitlab Inc

Gitlab is trending as investors react to its latest financial report, which, despite beating recent revenue and EPS figures, presented weaker-than-anticipated forward guidance, sparking a polarized discussion about its growth trajectory and high stock-based compensation amid broader software sector concerns and persistent buyout speculation.

Kraken Robotics, Inc. engages in the design, manufacture, and sale of software-centric sensors, subsea batteries, thrusters and underwater robotic systems. It operates through the following geographical segments: Asia Pacific, Europe, Middle East and Africa, North America, and Other. The company was founded on May 14, 2008, and is headquartered in Mt. Pearl, Canada.

Kraken Robotics Inc

Kraken Robotics is trending following its strategic acquisition of Covelya Group, a "company-maker" deal that significantly expands its subsea technology offerings and market reach as a global prime contractor. The community is discussing the long-term bullish implications of this vertical integration and significant battery orders, alongside short-term concerns regarding share dilution.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Rigel Pharmaceuticals is trending due to preliminary Q4 financial results surpassing expectations, confirming profitability and strong product sales growth. This, alongside promising clinical data for its pipeline assets and an active biotech M&A landscape, fuels widespread community speculation about the company's significant undervaluation and potential for a strategic acquisition, despite persistent short interest.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors weigh its recent earnings beat and a new cancer drug approval against a subdued 2026 outlook. Community discussions are heavily focused on concerns about the efficacy and tolerability of its acquired obesity pipeline, particularly when compared to existing market leaders.

Ross Stores, Inc. engages in the operation of off-price retail apparel and home accessories stores. Its products include branded and designer apparel, accessories, footwear, and home fashions through the Dress for Less and dd's DISCOUNTS brands. The company was founded by Stuart G. Moldaw in 1957 and is headquartered in Dublin, CA.

Ross Stores, Inc.

Ross Stores is trending after reporting a significant Q4 earnings beat and robust Q1 sales outlook, fueled by strong customer response and operational improvements, though community conversation remains divided on whether the future guidance justifies its current valuation amidst a value-seeking consumer environment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bombardier continues climb as RBC raises PT, sees more upside

Investing.com -- Shares of   Bombardier Inc   (TSX:BBDb) soared 3% on Monday, lifting the stock to its highest level since 2011, after RBC (TSX:RY) Capital Markets increased its price target on the business jet manufacturer to C$175 from C$108. The call reflects growing investor confidence in the company’s long-term free cash flow potential and valuation re-rating despite near-term earnings remaining below Street estimates.

Bombardier’s U.S. shares (BDRBF) reached their highest level since January 2014 on Wednesday as Wall Street analysts lauded the Canadian business jet maker securing orders for 50 aircraft valued at $1.7 billion.On Monday, Bombardier said an undisclosed customer will purchase its Challenger and Global series of aircraft, holding options to acquire 70 more, bringing the total deal value to $4 billion if all the planes are purchased. The deliveries of the business jets, used by both government and private entities, are scheduled to begin in 2027.In May, the company said it expects to deliver more than 150 aircraft in 2025. It is ramping up operations globally, with service centers and other facilities set to open in the United Arab Emirates, the UK, and Australia.Its Toronto-listed shares also jumped on Wednesday. Canadian markets were closed on July 1 for the Canada Day holiday.Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/BDRBF">Bombardier</a> was in the ‘bullish’ while retail chatter was ‘extremely high.’“I can see it reaching 120s to even 130s if it keeps this up,” one user said.<stembedurl>https://stocktwits.com/ScreamingEagles/message/619727892</stembedurl>&nbsp;&nbsp;According to TheFly, Scotiabank upgraded Toronto-listed shares of Bombardier to ‘Outperform’ from ‘Sector Perform’ and noted that demand is seemingly rebounding with the tariff noise dissipating. The brokerage also reportedly said that Bombardier is "firing on all cylinders after a lacklustre Q1 order intake."According to a Bloomberg report, TD Cowen analyst Tim James noted airplane orders of similar scale is not common and it could aide in building investor confidence once more and lead to a stock re-rating.Bombardier’s U.S. shares have gained 58.5% this year.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/robinhood-stock-dips-after-open-ai-denies-links-to-tokenized-offering/chFjLIURcLf">Robinhood Stock Dips After OpenAI Denies Links To Tokenized Offering: 'We... Do Not Endorse It'</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Bombardier Challenger 604, from private company, preparing for take off on the Barcelona airport runway, in Barcelona, Spain, on March 5, 2025. 

Bombardier Stock Rockets To Over 11-Year High As Analysts Cheer $1.7B Jet Order: ‘Firing On All Cylinders’

The aircraft maker stated earlier this week that the buyer also has options to buy 70 more aircraft.

Bombardier Stock Rockets To Over 11-Year High As Analysts Cheer $1.7B Jet Order

Equity

Bombardier’s (BDRAF) U.S.-shares rose 2.2% in extended trading on Monday after the Canadian firm said it has received orders for 50 aircraft, alongside a service agreement, valued at $1.7 billion.The aircraft maker stated that an undisclosed customer will purchase the Challenger and Global series of aircraft, holding options to acquire 70 more, bringing the total deal value to $4 billion if all the planes are purchased. The deliveries of business jets, used by both government and private entities, are scheduled to begin in 2027.“This significant order underscores the competitive advantage Bombardier’s full scope of products and services brings to customers throughout the entire aircraft lifecycle, from design to delivery, then throughout the in-service journey,” said CEO Éric Martel in a statement.In May, the company said it expects to deliver more than 150 aircraft in 2025. It is ramping up operations globally, with service centers and other facilities set to open in the United Arab Emirates, the UK, and Australia.However, the company will look forward to a trade deal between Canada and the U.S. to mitigate tariff uncertainty.Retail sentiment on Stocktwits was in the ‘neutral’ (50/100) territory, while retail chatter was ‘normal.’“The company is well-positioned in the large and medium cabin business jet categories, with its flagship Global and Challenger series aircraft experiencing strong order demand. In particular, we consider its Global series best-in-class in the ultra-long-range jet market,” S&amp;P Global analysts said in June before upgrading the company’s credit rating.The rating agency also projected annual adjusted core profit growth to average in the high-single-digit percentage points over the next three years.<a href="https://stocktwits.com/symbol/BDRAF">Bombardier’s U.S. shares</a> have risen nearly 25% this year.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/aero-vironment-stock-slips-after-1-35-b-capital-raise-plan-to-bolster-drone-manufacturing/chFgCpzRR1F">AeroVironment Stock Slips After $1.35B Capital Raise Plan To Bolster Drone Manufacturing</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Bombardier Challenger 604, from TAG Aviation Malta company, preparing for take off on the Barcelona airport runway, in Barcelona, Spain, on March 5, 2025.

Bombardier Scores $1.7B Contract Win For Business Jets, Services

Bombardier’s (BDRAF) U.S.-shares rose 2.2% in extended trading on Monday after the Canadian firm said it has received orders for 50 aircraft, alongside a service agreement, valued at $1.7 billion.

The business jet deliveries are scheduled to begin in 2027.

Bombardier, Inc. engages in the design, building, and maintenance of aircraft. It operates through the Business Aircraft and Others segments. The Business Aircraft segment is involved in selling new aircraft, pre-owned aircraft, and defense aircraft, as well as services and support including parts, smart services, service centers, training, and technical publications. The Others segment refers to the sale of components related to commercial aircraft programs. The company was founded on June 19, 1902 and is headquartered in Dorval, Canada.

Current Price	$198.00
Prev Close	$199.00
Open	$198.00
Dividend Yield	0.00%
50-Day Moving Average	$182.48
Beta	0.65
Avg. Volume	410.53
PE Ratio	20.73

52-Week High	$200.00
52-Week Low	$53.38
Market Capitalization	$19.6B
EPS (Annual)	$9.57
Price to Book	-15.88
Revenue Per Employee	$505,343.91

BDRAF
Bombardier Inc. - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BDRAF News

BDRAFBombardier Inc. - Ordinary Shares - Class A